| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/1997 | CN1034662C Process for preparing tetrazde devivatives |
| 04/23/1997 | CN1034631C Process for producing new agent having antiphlogistic activity |
| 04/22/1997 | US5623081 Method for producing tetrahydrofuranyl compounds |
| 04/22/1997 | US5623073 Benzimidazole compounds |
| 04/22/1997 | US5623064 Purity; removal of protein |
| 04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
| 04/22/1997 | US5622994 Nitrone derivatives |
| 04/22/1997 | US5622993 Stick formulations for topical drug delivery of therapeutic agents and uses thereof |
| 04/22/1997 | US5622992 Administering topical aromatic releasing decongestant composition to treat nasal symptoms |
| 04/22/1997 | US5622991 High fat diet |
| 04/22/1997 | US5622990 Dry, roller compacted powder comprising low amount excipients, free of disintegrant |
| 04/22/1997 | US5622989 Amino-benzofuryl-and thienyl-derivatives |
| 04/22/1997 | US5622988 Administering xanthene derivative hemostatic agent |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622986 Water soluble antitumor agents |
| 04/22/1997 | US5622985 Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
| 04/22/1997 | US5622984 Amidinophenol derivatives |
| 04/22/1997 | US5622982 Enzyme inhibitors; antiinflammatory agents |
| 04/22/1997 | US5622981 Use of metabotropic receptor agonists in progressive neurodegenerative diseases |
| 04/22/1997 | US5622980 Oral compositions of H2-antagonists |
| 04/22/1997 | US5622978 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 04/22/1997 | US5622976 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 04/22/1997 | US5622975 Prophylaxis or treatment of cardiovascular disorders such as atherosclerosis, restenosis, inflammation, or malignant invasion |
| 04/22/1997 | US5622972 Method for treating a mammal infected with respiratory syncytial virus |
| 04/22/1997 | US5622970 Controlling graft rejection |
| 04/22/1997 | US5622969 Administering to human or animal suffering from allergic reaction of pulmonary system and other inflammatory disorders |
| 04/22/1997 | US5622968 Acenaphthyl substituted guanidines and methods of use thereof |
| 04/22/1997 | US5622965 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622960 Anticancer, antitumor agents |
| 04/22/1997 | US5622959 Method of treating retroviral infections in mammals |
| 04/22/1997 | US5622957 Inducers of tyrosine hydroxylase; treatment of depression and anxiety |
| 04/22/1997 | US5622955 Methods of treating cryptosporidium parvum |
| 04/22/1997 | US5622953 1-amino-3-phenoxy propane derivatives as modulator agents and their applications |
| 04/22/1997 | US5622952 Glycine receptor antagonists and the use thereof |
| 04/22/1997 | US5622951 Piperazine derivatives as 5-HT antagonists |
| 04/22/1997 | US5622949 Aids therapy |
| 04/22/1997 | US5622948 Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| 04/22/1997 | US5622946 Radiation sensitization using texaphyrins |
| 04/22/1997 | US5622943 Administering anti-progestin |
| 04/22/1997 | US5622942 Such as glycyrrhizin, glycyrrhetic acid or ester |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622940 Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622936 Complex of sugar with a phosphorus amide |
| 04/22/1997 | US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622848 Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
| 04/22/1997 | US5622834 Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture |
| 04/22/1997 | US5622723 Charging sufficient chlorpheniramine maleate to coacervation medium to saturate cyclohexane solvent, separating microcapsules |
| 04/22/1997 | US5622722 Mixture of water soluble active drug, microcrystalline cellulose and sugar |
| 04/22/1997 | US5622721 Dosage forms of risedronate |
| 04/22/1997 | US5622720 Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
| 04/22/1997 | US5622717 Ulcer prevention method using a melt-spun hydrogel |
| 04/22/1997 | US5622716 Sustained release; drug delivery |
| 04/22/1997 | US5622709 Injectable |
| 04/22/1997 | US5622686 Diagnosis and treatment of viral effects using magnetic metal transferrin particles |
| 04/22/1997 | CA2029776C Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them |
| 04/22/1997 | CA2015235C Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent |
| 04/21/1997 | CA2188238A1 Injectable gaseous no/co2 composition |
| 04/18/1997 | CA2187989A1 Nefazodone: treatment of panic attack |
| 04/17/1997 | WO1997014038A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | WO1997013861A1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/17/1997 | WO1997013857A1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 04/17/1997 | WO1997013856A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | WO1997013854A1 Pilosulin 2 |
| 04/17/1997 | WO1997013845A2 Phosphopantetheinyl transferases and uses thereof |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013777A1 Novel orthosomycins from micromonospora carbonacea |
| 04/17/1997 | WO1997013776A2 Novel amine derivatives of epipodophyllotoxin 2', 3'-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer |
| 04/17/1997 | WO1997013774A2 Novel 5-o-deosaminyl 6-o-methyl erythronolide a derivatives, preparation method therefor and use thereof for preparing biologically active materials |
| 04/17/1997 | WO1997013772A2 Cephalosporin antibiotics |
| 04/17/1997 | WO1997013771A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/17/1997 | WO1997013770A1 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use |
| 04/17/1997 | WO1997013769A1 Disubstituted piperidine derivatives |
| 04/17/1997 | WO1997013768A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 04/17/1997 | WO1997013764A1 Lipophilic benzothiophenes |
| 04/17/1997 | WO1997013759A1 Pyrimidin derivatives |
| 04/17/1997 | WO1997013758A1 Pyridazinones as endothelin-receptor antagonists |
| 04/17/1997 | WO1997013757A1 Pyrazolone derivatives |
| 04/17/1997 | WO1997013755A1 1,3,5-trisubstituted pyrazoles for treament of inflammation |
| 04/17/1997 | WO1997013754A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 04/17/1997 | WO1997013753A1 Process for the preparation of anti-malarial drugs |
| 04/17/1997 | WO1997013751A1 Indole carbamates as leukotriene antagonists |
| 04/17/1997 | WO1997013744A1 3-amino-propoxyphenyl derivatives (i) |
| 04/17/1997 | WO1997013529A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 04/17/1997 | WO1997013528A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/17/1997 | WO1997013527A1 Treatments of helicobacter pylori infections |
| 04/17/1997 | WO1997013521A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 04/17/1997 | WO1997013520A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | WO1997013518A1 Treatment of pruritus with vitamin d and analogs thereof |
| 04/17/1997 | WO1997013517A1 Aqueous eye drops containing apafant as principal agent |
| 04/17/1997 | WO1997013516A1 Antibacterial composition for oral administration |
| 04/17/1997 | WO1997013515A1 Carbostyril derivative for curing ophthalmological diseases |
| 04/17/1997 | WO1997013514A1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 04/17/1997 | WO1997013513A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/17/1997 | WO1997013512A1 N-[2-substituted-3-(2-aminoethyl)-1h-indol-5-yl]-amides: new 5-ht1f agonists |